World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
48931
World Ranking
6701
National Ranking
3537

Maria E. Suarez-Almazor publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Maria E. Suarez-Almazor sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 497 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Maria E. Suarez-Almazor D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Maria E. Suarez-Almazor sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Maria E. Suarez-Almazor is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with a strong emphasis on oncology and rheumatology as subfields of study.

Their work spans multiple high-impact topics, including:

  • Cancer Immunotherapy and Biomarkers
  • Rheumatoid Arthritis Research and Therapies
  • Chronic Lymphocytic Leukemia Research
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • CAR-T Cell Therapy Research
  • Colorectal Cancer Treatments and Studies

Recent publications by Maria E. Suarez-Almazor demonstrate contributions to understanding immune-related adverse events and inflammation in cancer therapy contexts. Selected papers include:

  • Immune-related adverse events of checkpoint inhibitors, 2020, Nature Reviews Disease Primers
  • Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors, 2020, Arthritis & Rheumatology
  • Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology, 2023, Journal for ImmunoTherapy of Cancer
  • Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy, 2022, Nature Communications
  • Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events, 2023, Journal for ImmunoTherapy of Cancer

The scientist has collaborated frequently with several co-authors, including María A. López-Olivo, Noha Abdel-Wahab, Susan J. Bartlett, Juan Ignacio Ruiz, and Xerxes Pundole. Collaboration counts with these co-authors range from 16 to 44 joint publications.

Maria E. Suarez-Almazor has published extensively in journals such as:

  • Arthritis Care & Research
  • Seminars in Arthritis and Rheumatism
  • Supportive Care in Cancer
  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology

Additionally, they have contributed to book publications, including a recent work titled Multidisciplinary Management of Cancer Patients with Immune-Related Adverse Events from Checkpoint Inhibitors, published in 2023 by Frontiers Media.

Best Publications

  • International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

    Ross E Petty;Taunton R Southwood;Prudence Manners;John Baum

  • Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

    Julie R. Brahmer;Christina Lacchetti;Bryan J. Schneider;Michael B. Atkins

  • 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

    Jasvinder A. Singh;Daniel E. Furst;Aseem Bharat;Jeffrey R. Curtis

  • Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

    I. Puzanov;A. Diab;K. Abdallah;C. O. Bingham

  • Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.

    R. E. Petty;T. R. Southwood;J. Baum;E. Bhettay

  • Immune-related adverse events of checkpoint inhibitors.

    Manuel Ramos-Casals;Julie R. Brahmer;Margaret K. Callahan;Margaret K. Callahan;Alejandra Flores-Chávez

  • Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study.

    Peter G. Lawlor;Bruno Gagnon;Isabelle L. Mancini;Jose L. Pereira

  • Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication?

    Carol M. Ashton;Paul Haidet;Paul Haidet;Debora A. Paterniti;Debora A. Paterniti;Tracie C. Collins;Tracie C. Collins

  • Retention in care: a challenge to survival with HIV infection.

    Thomas P. Giordano;Thomas P. Giordano;Thomas P. Giordano;Allen L. Gilford;Allen L. Gilford;A. Clinton White;A. Clinton White;Maria E. Suarez-Almazor;Maria E. Suarez-Almazor;Maria E. Suarez-Almazor

  • Biologics for rheumatoid arthritis: an overview of Cochrane reviews.

    Jasvinder A. Singh;Robin Christensen;George A. Wells;Maria Suarez-Almazor

  • Understanding the pain experience in hip and knee osteoarthritis – an OARSI/OMERACT initiative

    G.A. Hawker;L. Stewart;M.R. French;J. Cibere

  • Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

    Bryan J Schneider;Jarushka Naidoo;Bianca D Santomasso;Christina Lacchetti

  • The effect of age on pain, function, and quality of life after total hip and knee arthroplasty.

    C. Allyson Jones;Donald C. Voaklander;D. William C. Johnston;Maria E. Suarez-Almazor

  • Opioid rotation for toxicity reduction in terminal cancer patients.

    Noe´mi D. de Stoutz;Eduardo Bruera;Maria Suarez-Almazor

  • Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports

    Noha Abdel-Wahab;Noha Abdel-Wahab;Mohsin Shah;Maria E. Suarez-Almazor

  • Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: A systematic review

    Noha Abdel-Wahab;Mohsin Shah;Maria A. Lopez-Olivo;Maria E. Suarez-Almazor

  • Clinical Survival Predictors in Patients With Advanced Cancer

    Antonio Viganó;Eduardo Bruera;Eduardo Bruera;Gian S. Jhangri;Stephen C. Newman

  • Survival prediction in terminal cancer patients: a systematic review of the medical literature.

    Antonio Viganò;Marlene Dorgan;Jeanette Buckingham;Eduardo Bruera

  • Variables in organ donors that affect the recovery of human islets of Langerhans.

    Lakey;Warnock Gl;Rajotte Rv;Suarez-Alamazor Me

  • Development and preliminary psychometric testing of a new OA pain measure – an OARSI/OMERACT initiative

    G. A. Hawker;A. M. Davis;M. R. French;J. Cibere

Frequent Co-Authors

Peter Tugwell
Peter Tugwell University of Ottawa
Anthony S. Russell
Anthony S. Russell University of Alberta
George A. Wells
George A. Wells University of Ottawa
Jasvinder A. Singh
Jasvinder A. Singh Veterans Health Administration
Adi Diab
Adi Diab The University of Texas MD Anderson Cancer Center
Robin Christensen
Robin Christensen University of Southern Denmark
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Lyn March
Lyn March University of Sydney
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Sharon H. Giordano
Sharon H. Giordano The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees is a practical alternative for those interested in medical careers but seeking flexible study options. For non-nurses, online msn programs for non nurses offer a direct route to a Master of Science in Nursing, allowing career changers to enter advanced nursing roles without a prior nursing degree.

Entry-level nursing programs are also becoming more accessible. Several schools offer online adn programs for non nurses, which provide a streamlined pathway to becoming a registered nurse. Applicants can find programs that emphasize flexibility with minimal on-campus requirements.

For those interested in administrative roles, the best online medical billing and coding schools offer accredited training and financial aid opportunities. These credentials can quickly launch a career in the fast-growing field of health information management.

Lastly, students looking for a less traditional pathway can consider LPN programs. Certain lpn school without teas test requirements eliminate common entrance exams, making it easier to start your nursing education journey.

Best Scientists Citing Maria E. Suarez-Almazor

Trending Scientists

Recently Published Articles